NIAID Banner Logo Image


1. 61500 OI-LS-381; SCIFINDER-OI-8/13/2007

Thuggacins, macrolide antibiotics active against Mycobacterium tuberculosis: isolation from myxobacteria, structure elucidation, conformation analysis and biosynthesis

Steinmetz, Heinrich, Irschik, Herbert, Kunze, Brigitte, Reichenbach, Hans, Hoefle, Gerhard, and Jansen, Rolf

Chem.--Eur. J. 2007. 13(20): 5822-5832

2. 61501 OI-LS-381; SCIFINDER-OI-8/13/2007

Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps

Amaral, Leonard, Martins, Marta, and Viveiros, Miguel

J. Antimicrob. Chemother. 2007. 59(6): 1237-1246

3. 61502 OI-LS-381; WOS-OI-8/10/2007

Synthesis of Putative Chain Terminators of Mycobacterial Arabinan Biosynthesis

Smellie, I. et al.

Organic & Biomolecular Chemistry 2007. 5(14): 2257-2266


4. 61503 OI-LS-381; SCIFINDER-OI-8/13/2007

Efficacy of clarithromycin on Mycobacterium avium which proliferates in bronchial epithelial cells

Yamazaki, Yoshitaka

Jpn. J. Antibiot. 2007. 60(Suppl. A): 28-31

5. 61504 OI-LS-381; WOS-OI-8/10/2007

New Anti-Tuberculosis Therapies

Portero, J. and Rubio, M.

Expert Opinion on Therapeutic Patents 2007. 17(6): 617-637


6. 61505 OI-LS-381; SCIFINDER-OI-8/13/2007

IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy

Roque Susana, Nobrega Claudia, Appelberg Rui, and Correia-Neves Margarida

J Immunol 2007. 178(12): 8028-35.

7. 61506 OI-LS-381; SCIFINDER-OI-8/13/2007

Invasion and Egress by the obligate intracellular parasite Toxoplasma gondii: potential targets for the development of new antiparasitic drugs

Lavine, MD and Arrizabalaga, G

Curr. Pharm. Des. 2007. 13(6): 641-651

8. 61507 OI-LS-381; SCIFINDER-OI-8/13/2007

Coordination to copper(II) strongly enhances the in vitro antimicrobial activity of pyridine-derived N(4)-tolyl thiosemicarbazones

Mendes, Isolda C, Moreira, Juliana P, Mangrich, Antonio S, Balena, Solange P, Rodrigues, Bernardo L, and Beraldo, Heloisa

Polyhedron 2007. 26(13): 3263-3270

9. 61508 OI-LS-381; SCIFINDER-OI-8/13/2007

Antioxidant, antimalarial and antimicrobial activities of tannin-rich fractions, ellagitannins and phenolic acids from Punica granatum L

Reddy, Muntha K, Gupta, Sashi K, Jacob, Melissa R, Khan, Shabana I, and Ferreira, Daneel

Planta Med. 2007. 73(5): 461-467

10. 61509 OI-LS-381; SCIFINDER-OI-8/13/2007

Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C

Uyama, Hirokazu, Nakamura, Hideji, Hayashi, Eijiro, Ogawa, Hiroyuki, Enomoto, Hirayuki, Yoshida, Kenya, Okuda, Yorihide, Yamamoto, Mitsunari, Hada, Toshikazu, and Hayashi, Norio

Hepatol. Res. 2007. 37(5): 325-330

11. 61510 OI-LS-381; SCIFINDER-OI-8/13/2007

Preparation of azacytosine acyclic nucleotide derivatives useful as antiviral agents

Holy, Antonin, Krecmerova, Marcela, Piskala, Alois, Andrei, Graciela, Snoeck, Robert, De Clercq, Erik, Neyts, Johan, and Naesens, Lieve

PATENT: WO 2007065231 ISSUE DATE: 20070614

APPLICATION: 2006 PP: 96pp.

ASSIGNEE: (K.U. Leuven Research & Development, Belg. and Institute of Organic Chemistry and Biochemistry of Academy of Sciences of the Czech Republic)

12. 61511 OI-LS-381; SCIFINDER-OI-8/13/2007

Mechanism of drug-resistance in human cytomegalovirus

Eizuru Yoshito

Nippon Rinsho 2007. 65 Suppl 2 Pt. 1: 476-9.

13. 61512 OI-LS-381; SCIFINDER-OI-8/13/2007

Antivirals for herpesviruses and cytomegalovirus

Minematsu Toshio

Nippon Rinsho 2007. 65 Suppl 2 Pt. 1: 396-400.

14. 61513 OI-LS-381; SCIFINDER-OI-8/13/2007

Structural characterization and antifungal studies of some mixed ligand schiff base complexes with 6-bromo-2-thio 3-phenyl quinazoline-4(3H) one thiosemicarbazone

Rai, BK, Choudhary, Pramod, Rana, Sweta, and Sahi, Poonam

Orient. J. Chem. 2007. 23(1): 271-275

15. 61514 OI-LS-381; WOS-OI-8/17/2007

Therapeutic Efficacy of Posaconazole Against Isolates of Candida Albicans With Different Susceptibilities to Fluconazole in a Vaginal Model

Gonzalez, G. et al.

Medical Mycology 2007. 45(3): 221-224

16. 61515 OI-LS-381; WOS-OI-8/17/2007

Binding-Site Identification and Genotypic Profiling of Hepatitis C Virus Polymerase Inhibitors

Pauwels, F. et al.

Journal of Virology 2007. 81(13): 6909-6919


17. 61516 OI-LS-381; SCIFINDER-OI-8/13/2007

Synthesis and antimicrobial activity of some novel 2-(4-substituted-phenyl)-5- (naphthalen-1-yloxy-methyl) [1,3,4] oxadiazoles and 1-[2-(4-substituted phenyl)-5-(naphthaten-1- yloxy-methyl)-[1,3,4]oxadiazol-3-yl]-ethanones

Rajak, Harish, Kharya, Murlidhar, and Mishra, Pradeep

Int. J. Chem. Sci. 2007. 5(1): 365-379

18. 61517 OI-LS-381; WOS-OI-8/17/2007

Synthesis of Methylene-Bridged Analogues of Biologically Active Pteridine Derivatives

Slusarczyk, M. et al.

European Journal of Organic Chemistry 2007.(18): 2987-2994


19. 61518 OI-LS-381; WOS-OI-8/17/2007

Hts, Chemical Hybridization, and Drug Design Identify a Chemically Unique Antituberculosis Agent-Coupling Serendipity and Rational Approaches to Drug Discovery

Mao, J. et al.

Chemmedchem 2007. 2(6): 811-813


20. 61519 OI-LS-381; PUBMED-OI-8/20/2007

Characterization of the metabolic activation of a HCV nucleoside inhibitor beta -D-2'-deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species

Ma, H, Jiang, WR, Robledo, N, Leveque, V, Ali, S, Lara-Jaime, T, Masjedizadeh, M, Smith, DB, Cammack, N, Klumpp, K, and Symons, J

J Biol Chem 2007.


21. 61520 OI-LS-381; PUBMED-OI-8/20/2007

Synthesis and Enzyme Inhibitory Activity of the S-Nucleoside Analogue of the Ribitylaminopyrimidine Substrate of Lumazine Synthase and Product of Riboflavin Synthase

Talukdar, A, Illarionov, B, Bacher, A, Fischer, M, and Cushman, M

J Org Chem 2007.


22. 61521 OI-LS-381; PUBMED-OI-8/20/2007

Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by Novel Dideoxy Nucleosides

Rai, D, Johar, M, Srivastav, NC, Manning, T, Agrawal, B, Kunimoto, DY, and Kumar, R

J Med Chem 2007.


23. 61522 OI-LS-381; PUBMED-OI-8/20/2007

Identification of Inhibitors for Mycobacterial Protein Tyrosine Phosphatase B (MptpB) by Biology-Oriented Synthesis (BIOS)

Correa, IR Jr, Noren-Muller, A, Ambrosi, HD, Jakupovic, S, Saxena, K, Schwalbe, H, Kaiser, M, and Waldmann, H

Chem Asian J 2007.


24. 61523 OI-LS-381; PUBMED-OI-8/20/2007

Design, Synthesis, and Pharmacological Evaluation of Mefloquine-Based Ligands as Novel Antituberculosis Agents

Mao, J, Wang, Y, Wan, B, Kozikowski, AP, and Franzblau, SG

ChemMedChem 2007.


25. 61524 OI-LS-381; PUBMED-OI-8/20/2007

Chemoenzymatic synthesis of feruloyl D: -arabinose as a potential anti-mycobacterial agent

Vafiadi, C, Topakas, E, Alderwick, LJ, Besra, GS, and Christakopoulos, P

Biotechnol Lett 2007.


26. 61525 OI-LS-381; PUBMED-OI-8/20/2007

Morphine Inhibits Intrahepatic Interferon- alpha Expression and Enhances Complete Hepatitis C Virus Replication

Li, Y, Ye, L, Peng, JS, Wang, CQ, Luo, GX, Zhang, T, Wan, Q, and Ho, WZ

J Infect Dis 2007. 196(5): 719-30


27. 61526 OI-LS-381; PUBMED-OI-8/20/2007

Antifungal potential of disulfiram

Khan, S, Singhal, S, Mathur, T, Upadhyay, DJ, and Rattan, A

Nippon Ishinkin Gakkai Zasshi 2007. 48(3): 109-13


28. 61527 OI-LS-381; PUBMED-OI-8/20/2007

Identification and characterization of an aspartyl protease from Cryptococcus neoformans

Pinti, M, Orsi, CF, Gibellini, L, Esposito, R, Cossarizza, A, Blasi, E, Peppoloni, S, and Mussini, C

FEBS Lett 2007. 581(20): 3882-6


29. 61528 OI-LS-381; PUBMED-OI-8/20/2007

Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells

Johann, S, Soldi, C, Lyon, JP, Pizzolatti, MG, and Resende, MA

Lett Appl Microbiol 2007. 45(2): 148-53


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024